Enliven Therapeutics
ELVN | NASDAQ
$47.62
-$1.18 (-2.42%)
At close: Nov 16, 2026, 4:00 PM ET
$47.62
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Enliven Therapeutics Statistics
Key statistics explainedMarket Data
$3.71B
$2.83B
0.25
1.31M
77.98M
25.59%
N/A
NASDAQ
US29337E1029
Price Performance
27.6%
-20.0%
20.2%
209.2%
118.8%
357.9%
275.6%
27.6%
115.8%
30.1%
-3.0%
Valuation
-28.35
N/A
-3.51
17.60
N/A
742,700.60
4.23
-55.92
-34.36
-56.02
N/A
-24.94
-24.96
-42.62
-3.5%
-1.8%
-2.9%
Financial Health
$884.35M
$1.32M
$884.35M
$897.23M
45.95
45.95
0.00
-0.01
-0.02
-50.35
0.00
112.68
3
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-62.8%
Returns
-12.7%
-16.9%
-15.4%
-15.4%
-12.7%
Historical Growth (CAGR)
N/A
N/A
N/A
6.1%
37.8%
N/A
1.5%
-12.2%
N/A
Analyst Forecasts
Buy
6
-27.8%
N/A
Mar 2, 2027
-$0.47
-2.1%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$78.00
63.8%
Cash Flow
$-66.22M
$-66.41M
$-108.09M
-$0.85
-$0.85
0.0%
Income Statement
$0
$-46K
$-135.36M
$-113.4M
$-113.48M
-$1.68
N/A
$-1.69M
67
Add to Watchlist
Select watchlists to add or remove ELVN